灌注系統市場規模、佔有率及成長分析（按年齡層、應用、最終用戶和地區）- 產業預測 2025-2032

預計 2023 年全球灌注系統市場規模將達到 12.9 億美元，從 2024 年的 13.4 億美元成長到 2032 年的 18.2 億美元，預計在預測期內（2025-2032 年）的複合年成長率為 3.9%。

灌注系統市場在醫療保健和生物醫學研究中至關重要，尤其是在器官移植和細胞研究中。這些專門的設備可以將氧氣和富含營養的液體控制輸送到體外的活組織和器官，從而保持器官的運輸或實驗的可行性。由於灌注系統提高了捐贈器官的保存率和移植成功率，全球器官短缺導致器官移植需求不斷增加，推動了市場的成長。常溫灌注等技術創新延長了器官維持時間並改善了活力評估。此外，在製藥和生物技術研究中，灌注系統促進細胞和組織培養並模擬疾病研究和治療開發的生理條件。對這些技術的投資預計將改善臨床結果和研究能力，推動市場成長。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

灌注系統市場規模（依年齡層）

• 市場概覽
• 成人
• 孩子們

灌注系統市場規模（依應用）

• 市場概覽
• 心肺灌注系統
  • 供氧設備
  • 體外循環
  • 灌注幫浦
  • 套管
  • 監控系統
  • 其他
  • 動脈過濾器
  • 水庫
  • 資料管理系統
  • 心臟麻痹驟停輸送系統
  • 熱交換器
  • 配件
• 細胞灌注系統
  • 生物反應器灌注系統
  • 微流體灌注系統
  • 重力/壓力驅動灌注系統
  • 哺乳動物小器官灌注系統
• 離體器官灌注系統
  • 低溫
  • 常溫
• 體外膜氧合（ECMO）
• 離體器官灌注系統

灌注系統市場規模（依最終用戶分類）

• 市場概覽
• 醫院和 ASC
• 專科診所
• 其他

灌注系統市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較比較（2022-2024 年）

主要企業簡介

• ICU Medical（United States）
• B. Braun（Germany）
• Delcath Systems（United States）
• Fresenius Medical Care（Germany）
• Terumo Corporation（Japan）
• Medtronic（Ireland）
• Getinge AB（Sweden）
• LivaNova（United Kingdom）
• Edwards Lifesciences（United States）
• Nipro Corporation（Japan）
• CytoSorbents Corporation（United States）
• Spectrum Medical（United Kingdom）
• Eurosets（Italy）
• Biomedica（Austria）
• Soma Technology（United States）

結論和建議

Global Perfusion System Market size was valued at USD 1.29 billion in 2023 and is poised to grow from USD 1.34 billion in 2024 to USD 1.82 billion by 2032, growing at a CAGR of 3.9% during the forecast period (2025-2032).

The perfusion system market is crucial in medical and biomedical research, particularly for organ transplantation and cellular studies. These specialized devices enable controlled delivery of oxygenated and nutrient-dense fluids to biological tissues or organs outside the body, preserving organ viability for transport and experimentation. The market's growth is driven by the rising demand for organ transplants amidst a global organ shortage, as perfusion systems enhance donor organ preservation and transplant success rates. Innovations like normothermic perfusion extend organ maintenance time and improve viability assessment. Additionally, in pharmaceutical and biotechnology research, perfusion systems facilitate cell and tissue culture, simulating physiological conditions for disease study and treatment development. Investment in these technologies is expected to propel market growth, enhancing clinical outcomes and research capabilities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Perfusion System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Perfusion System Market Segments Analysis

Global Perfusion System Market is segmented by Age Group, Application, End User and region. Based on Age Group, the market is segmented into Adults and Pediatrics. Based on Application, the market is segmented into Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System, Extracorporeal Membrane Oxygenation (ECMO) and Isolated Organ Perfusion Systems. Based on End User, the market is segmented into Hospitals & ASCs, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Perfusion System Market

The rising incidence of organ failure and the heightened demand for transplantable organs significantly propel the global perfusion system market. These innovative systems are vital for preserving and evaluating donor organs, ultimately enhancing the success rates of transplantation procedures. As the need for effective organ preservation techniques escalates, perfusion systems become increasingly crucial in ensuring that donor organs remain viable for transplantation. This growing reliance on advanced perfusion technology underscores its importance in the healthcare landscape, as it not only addresses the challenges associated with organ availability but also aims to improve patient outcomes in transplantation.

Restraints in the Global Perfusion System Market

The Global Perfusion System market faces significant obstacles due to rigorous regulatory demands and the necessity for adherence to high safety and quality standards. These stringent requirements can delay the innovation, development, and approval processes for new perfusion technologies, hindering the timely introduction of advanced solutions into the market. As companies strive to meet these complex regulations, the pace of technological advancements may be impeded, ultimately affecting their ability to commercialize enhanced perfusion systems. This complex landscape presents challenges that can slow down growth and limit opportunities within the industry, impacting overall market dynamics.

Market Trends of the Global Perfusion System Market

The Global Perfusion System market is witnessing a significant trend towards normothermic perfusion, which is rapidly gaining traction among healthcare professionals and transplant centers. This innovative approach maintains donor organs at physiological temperatures during transportation, enhancing their viability and extending preservation times. As a result, it facilitates thorough evaluation of organ function prior to transplantation, thereby increasing the likelihood of successful grafting and improving patient outcomes. The growing emphasis on optimizing organ preservation techniques and the rising demand for transplantable organs are driving investment and research into normothermic perfusion systems, making them a key focus area in the evolving landscape of the perfusion market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Perfusion System Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Adults
• Pediatrics

Global Perfusion System Market Size by Application & CAGR (2025-2032)

• Market Overview
• Cardiopulmonary Perfusion System
  • Oxygenators
  • Heart-Lung Machine
  • Perfusion Pumps
  • Cannula
  • Monitoring System
  • Others
  • Arterial Filters
  • Reservoirs
  • Data Management Systems
  • Cardioplegia Delivery Systems
  • Heat Exchangers
  • Accessories
• Cell Perfusion System
  • Bioreactor Perfusion System
  • Microfluidic Perfusion System
  • Gravity/Pressure-driven Perfusion System
  • Small Mammal Organ Perfusion System
• Ex-Vivo Organ Perfusion System
  • Hypothermic
  • Normothermic
• Extracorporeal Membrane Oxygenation (ECMO)
• Isolated Organ Perfusion Systems

Global Perfusion System Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & ASCs
• Specialty Clinics
• Others

Global Perfusion System Market Size & CAGR (2025-2032)

• North America (Age Group, Application, End User)
  • US
  • Canada
• Europe (Age Group, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Age Group, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Age Group, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Age Group, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ICU Medical (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delcath Systems (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Medical Care (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CytoSorbents Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Medical (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurosets (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biomedica (Austria)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soma Technology (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations